🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

🧬 TWEETORIAL/X'torial: Why Every Rare Cancer Patient Deserves Molecular Profiling 🧬 1/15 🚨 Here's a shocking fact: Rare cancers make up 25% of ALL cancer cases, yet most patients never get the molecular testing that could save their lives. 👉In our policy & practice paper -

Always so inspiring AACR President Lillian L. Siu Prof Lilian Siu’s Keynote insights ESMO - Eur. Oncology #ESMOTATAsia25 🌏Play to our strengths & 👀 opportunities to collab/complementary trials 🌏Strategies to improve equity/access to trials 🌏visions for P1 trials to be patient focus, not just 💊focused

📈 Early-Onset GI Cancers. A review. 🔗 jamanetwork.com/journals/jamao… In 2022, CRC led (54%), followed by gastric (24%), esophageal (13%), and pancreatic (9%). 🧬 15–30% have germline variants 📉 Prognosis same or worse than later-onset ⚠️ Prevention & early detection needed

Bishal Gyawali, MD, PhD, FASCO reminds us to communicate clearly on both publications & end of life care, infused w a bit of humor & humanity. Checklist for RCT pubs: pubmed.ncbi.nlm.nih.gov/39914429/ ANZUP #ANZUP25

Global burden of early-onset colorectal cancer - SURGERY Journal surgjournal.com/article/S0039-… Edward Christopher "Chris" Dee, MD Memorial Sloan Kettering Cancer Center

🧵1/ 📢 Just published: Proceedings of the 1st biannual bridging the gaps in lung cancer conference - a landmark conference uniting top oncology experts to tackle today’s biggest controversies in lung cancer care. Let’s dive into the key takeaways 🔗 academic.oup.com/oncolo/article…

How accurately are racial minorities represented in US cancer registration systems? Analysis reveals disparities despite revisions to established standards for race data collection. acsjournals.onlinelibrary.wiley.com/doi/10.1002/cn… National Cancer Institute OncoAlert

The rise of China’s pharmaceutical industry from 2015–2024 nature.com/articles/d4157… This new article analyses the growth in drug innovation in China, the underlying environmental factors and strategic trends such as the outlicensing of assets originating in Chinese companies

Findings from this new National Cancer Institute researcher-led study underscore the importance of equitable access to healthcare advancements and the need for targeted interventions to address these disparities. acsjournals.onlinelibrary.wiley.com/doi/10.1002/cn… OncoAlert #CancerDisparities

📜 In SURGERY Journal led by Davidi Tawfiles, we describe the #global burden of #early onset #colorectal #cancer ❗We find that EOCRC rates are expected to double in many parts of the world 🙏 Our global team including patient advocates! 🌎 🌍 🌏 🔗 surgjournal.com/article/S0039-…

👍 Good news from this year’s #CancerAnnualReport: Cancer mortality has dropped in men & women for 20+ years, even during the 1st 2 years of the pandemic. Cancer incidence among children fell (2015–2021) & mortality keeps declining. acsjournals.onlinelibrary.wiley.com/doi/full/10.10… OncoAlert National Cancer Institute

The amazing Leah Phillips and YLCI is featured in this article on the front page of The New York Times ! So proud of you Leah - Let’s keep changing the face of lung cancer 🤍🤍🤍

Too many people are still diagnosed with #lungcancer far too late. We must find ways to detect this disease earlier — for everyone. Grateful for advocates like Leah & my friends at Young Lung Cancer Initiative leading the way. nytimes.com/2025/07/22/wel… #LCSM The New York Times

New @NatureRevDrugDisc “Analyst’s Couch” on the NSCLC drug market: sales are projected to climb from US$31.7B (2024) to $56.1B by 2032 (Clarivate). NSCLC accounts for ~85% of lung cancers—major unmet needs persist across lines of therapy. Read more: nature.com/articles/d4157…

In this analysis of >8k patients with #GIcancers: 👉45% (n=3,764) had a COST score of <26, indicating #financialToxicity 👉28% (n=2,321) reported at least 1 health related social risk... including > 1️⃣in🔟 who couldn't afford 🍔🥗, 🛏️🏡, or 🚗🚐 ascopubs.org/doi/pdfdirect/…

“Many Lung Cancers Are Now in Nonsmokers.” The New York Times tells the story of a shifting epidemic: lung cancer among people, mostly women — who’ve never smoked. The face of lung cancer is changing. 🔗 nytimes.com/2025/07/22/wel…

Available JTO & JTO CRR - the 2024 IASLC Global Survey on Biomarker Testing. Majority (67%) reported most patients had biomarker testing (up from 39% in 2018) but 43% sometimes treated before results. Barriers: cost, time, tissue, access, awareness. jto.org/article/S1556-…

🩸 Join the EQUAL Study! Asian or Hispanic & a non-smoker? Help us detect lung cancer early. ✅ Blood test ✅ Quick survey ✅ Optional focus group & biobank 💳 Gift cards included! Your participation matters. 🔗 equalstudy.dana-farber.org #LungCancer #EQUALStudy

ACS Research led by Qinran Liu JNCI showed disparities in #breastcancer & cervical #cancer stage at dx by racial & economic segregation in #NYC. No disparities for #CRC may in part reflect local initiatives to ↑ #CRC early dx, eg, the C5 coalition. doi.org/10.1093/jnci/d…

Hello friends😊 Just submitted my Hematology/Oncology fellowship application 🙌 Grateful to my #mentors, BCM Department of Medicine, and #friends/family whose support and encouragement shaped this journey 🌟📜 Looking forward to connecting with amazing fellows and faculty 🍀‼️